Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of nifedipine sustained-release tablet composition

A technology for nifedipine and nifedipine, which is applied in the field of nifedipine sustained-release tablet composition and preparation thereof, can solve the problems of unstable dissolution, unstable particle size, etc., achieve better pharmacoeconomics, and ensure effective and durable , reducing the effect of headache

Active Publication Date: 2020-08-07
DISHA PHARMA GRP
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the actual preparation work, it was found that the particle size of nifedipine sustained-release tablets needs to be strictly controlled, and the instability of particle size will lead to the instability of dissolution

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of nifedipine sustained-release tablet composition
  • A kind of nifedipine sustained-release tablet composition
  • A kind of nifedipine sustained-release tablet composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Nifedipine 20g (D90 is 105.5μm), lactose 40g, corn starch 5g, Tween-80 5g, microcrystalline cellulose 8g, magnesium stearate 1g, film coating premix (Colorcon, the model is 295F620084 , the ingredients are hypromellose, macrogol 4000, titanium dioxide, ferric oxide) 4g. Prepare 1000 tablets according to the preparation method described in the technical scheme part of the description.

Embodiment 2

[0029] Example 2 Nifedipine 20g (D90 is 105.5μm), lactose 44g, corn starch 5g, Tween-80 7g, microcrystalline cellulose 8g, magnesium stearate 1g, film coating premix (Colorcon, The model is 295F620084, and the ingredients are hypromellose, macrogol 4000, titanium dioxide, iron sesquioxide) 4g. Prepare 1000 tablets according to the preparation method described in the technical scheme part of the description.

Embodiment 3

[0030] Example 3 Nifedipine 20g (D90 is 105.5μm), lactose 36g, corn starch 5g, Tween-80 6g, microcrystalline cellulose 12g, magnesium stearate 1g, film coating premix (Colorcon, The model is 295F620084, and the ingredients are hypromellose, macrogol 4000, titanium dioxide, iron sesquioxide) 4g. Prepare 1000 tablets according to the preparation method described in the technical scheme part of the description.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
specific surface areaaaaaaaaaaa
weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to a nifedipine sustained-release tablet composition and a preparation method thereof. The nifedipine sustained-release tablet composition of the invention comprises nifedipine,tween-80, lactose, microcrystalline cellulose, corn starch, and that D90 of nifedipine is 95-135 [mu] m, the mass ratio of lactose to nifedipine is 1.8: 1-2.2: 1, the dosage of Tween is 6-9%. As thattechnical scheme of the invention is reasonably adjust in composition, the process and equipment limit caused by the grinding fineness are avoided, and the tablet composition with low Cmax than the reference preparation and high AUC than the reference preparation is prepared.

Description

technical field [0001] The invention relates to a nifedipine slow-release tablet composition and a preparation method thereof, belonging to the technical field of pharmaceutical preparations. Background technique [0002] Hypertension is a common disease in our country, which requires life-long medication, which has a great impact on the life and health of the people and the cost of living. Nifedipine is an old drug of dipines for the treatment of hypertension. It has a huge market and good antihypertensive effect in my country. Its slow-release preparation can stably control the blood pressure of the human body and reduce blood pressure fluctuations of patients, so it has a broad market prospect. [0003] Nifedipine sustained-release tablets mostly use sustained-release matrix materials to achieve the sustained-release effect of nifedipine, but the original Bayer company patent (US526446) discloses that the insoluble characteristics of nifedipine can be used, and the specif...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/36A61K31/4422A61K47/26A61K47/38A61P9/12
CPCA61K9/2018A61K9/2054A61K9/2866A61K31/4422A61P9/12
Inventor 金栋霞候铁强白莉高永吉
Owner DISHA PHARMA GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com